Legendary Hot Dogs and More from Sahlen’s
May 6, 2019
Only the Freshest and Highest Quality Meat Products
Hot dogs are as American as apple pie and the Fourth of July. We’ve been celebrating and enjoying this food staple for as long as we can remember.
Get excited because Alex Sahlen of Sahlen Packing Company is at The Balancing Act studio, ready to dish on her legendary family business, Sahlen’s, which is known for its premium quality hot dogs and more.
Sahlen Packing Company was founded in 1869 in Buffalo, New York as a family business, and company founder Joseph Sahlen dedicated himself to one guiding principle: only the freshest and highest quality meat products would bear the proud Sahlen name.
Today, in addition to being the name behind the Buffalo area’s favorite hot dogs and holiday hams, Sahlen’s has grown from its New York roots to offer “Old Fashioned” Smokehouse ham, hot dogs, and turkey breast in over 15 states. At company headquarters in Buffalo, NY, they operate a state-of-the-art processing facility which they continually update and expand to satisfy customer demands for a range of premium quality meat products.
Still Sahlen family owned and operated, they continue their dedication to the old-fashioned idea of providing customers with the finest products available.
Stay tuned as Alex gives us an inside look at Sahlen’s, while Chris Cauley, a Sahlen Packing “grill master,” demonstrates how to cook up the perfect hot dog.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.